GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Marksans Pharma Ltd (NSE:MARKSANS) » Definitions » Other Long Term Assets

Marksans Pharma (NSE:MARKSANS) Other Long Term Assets : ₹0 Mil (As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is Marksans Pharma Other Long Term Assets?

Marksans Pharma's other long-term assets for the quarter that ended in Dec. 2023 was ₹0 Mil.

Marksans Pharma's quarterly other long-term assets increased from Jun. 2023 (₹0 Mil) to Sep. 2023 (₹314 Mil) but then stayed the same from Sep. 2023 (₹314 Mil) to Dec. 2023 (₹0 Mil).

Marksans Pharma's annual other long-term assets increased from Mar. 2021 (₹50 Mil) to Mar. 2022 (₹65 Mil) and increased from Mar. 2022 (₹65 Mil) to Mar. 2023 (₹130 Mil).


Marksans Pharma Other Long Term Assets Historical Data

The historical data trend for Marksans Pharma's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marksans Pharma Other Long Term Assets Chart

Marksans Pharma Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.40 63.63 49.57 64.65 129.60

Marksans Pharma Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 129.60 - 313.62 -

Marksans Pharma Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


Marksans Pharma (NSE:MARKSANS) Business Description

Traded in Other Exchanges
Address
Veera Desai Extension Road, 11th Floor, Grandeur, Opposite Gundecha Symphony, Oshiwara, Andheri (West), Mumbai, MH, IND, 400053
Marksans Pharma Ltd is a pharmaceutical company. The company is engaged in the research, manufacturing, and marketing of pharmaceutical formulations. It manufactures analgesics, gastroenterology, anti-diabetic, cardiovascular, pain management, gynecology, gastrointestinal and oncologic drugs as well as antibiotics and antiallergic medications. It has a market presence with the majority of the revenue generated from the United States and North America, followed by Europe and the UK, Australia and New Zealand, India, and the Rest of the World.

Marksans Pharma (NSE:MARKSANS) Headlines

No Headlines